We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Stifel lowered PT to $25 from $36, and downgraded rating from "Buy". Stifel analysts said that while Baxter has made positive strides through portfolio transformation efforts and efficiency measures, ...

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Revenue grew 4% to $2.81 billion, slightly below expectations (GAAP), with international sales growth outpacing the U.S. but free cash flow remained negative and the full-year outlook was tightened.

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new ...

This was the stock's second consecutive day of losses.